Skip to content
Recall Observatory FDA recall evidence

Device product

cobas SARS-CoV-2 & Influenza A/B assay cobas Liat- Reagents, 2019-Novel Coronavirus Nucleic Acid for use on the cobas Liat System, Catalog Number: 09211101190

Z-1413-2021

March 25, 2021

Class II

Product summary

Firm
Roche Molecular Systems, Inc.
Event
Event 87622
Status
Ongoing
Classification
Class II
Quantity
US: 143,823 kits Ex-US: 57,219 kits
Official record key
device-enforcement:Z-1413-2021

Official wording

Reason: Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves

Code information: All lot numbers

Distribution pattern: Nationwide WorldWide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves